Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tiancheng Luo
Observed name:
Luo, Tiancheng
Institutions:
Xuzhou Medical College,
Affiliated Hospital of Xuzhou Medical College
Observed institutions:
Xuzhou Medical College,
Affiliated Hospital of Xuzhou Medical College
ORCID:
0009-0008-8139-3171
Observed ORCID:
0009-0008-8139-3171
OpenAlex ID:
A5121750139
BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares
2026
·
Xiaoyu Huang
, Zhouao Zhang
, et al.
·
Science Advances
·
19
PDF
Increased serum interleukin-41 correlates with disease severity in myasthenia gravis
2024
·
Zhouyi Wang
, Zhouao Zhang
, et al.
·
International Immunopharmacology
·
14
Eculizumab as a Fast-Acting Therapy in a Myasthenic Crisis Patient With Poor Response to Efgartigimod: A Case Report
2026
·
Zhouao Zhang
, Xinyan Guo
, et al.
·
The Neurologist
·
1
Aberrant expression of triggering receptor expressed on myeloid cell-1 is involved in the immunopathological mechanism of myasthenia gravis
2026
·
Zhouyi Wang
, Tiancheng Luo
, et al.
·
Autoimmunity
PDF
Aberrant expression of triggering receptor expressed on myeloid cell-1 is involved in the immunopathological mechanism of myasthenia gravis
2026
·
Wang, Zhouyi
, Luo, Tiancheng
, et al.
·
Figshare
Show more works
View as search
Works count:
5
Citation count:
34
H-index:
2
I10-index:
2
Year
Topic
Type